CROWE A DERRILL MD
SC 13G/A, 2000-02-11
Previous: HUMAN GENOME SCIENCES INC, SC 13G/A, 2000-02-11
Next: GUARDIAN LIFE INSURANCE CO OF AMERICA, SC 13G/A, 2000-02-11



<PAGE>   1


                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13G




                   Under the Securities Exchange Act of 1934

                               (Amendment No. 2)*

                            Medical Assurance, Inc.
- -------------------------------------------------------------------------------
                                (Name of Issuer)

                    Common Stock, $1.00 par value per share
- -------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                  58449U 10.0
                        ------------------------------
                                 (CUSIP Number)

Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item I; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other promotions of the Act (however, see the
Notes).


                               Page 1 of 8 pages


<PAGE>   2
CUSIP NO. 58449 U 10 O                    13G                  PAGE 2 OF 5 PAGES
         ---------------------                                     ---  ---

  (1)     NAMES OF REPORTING PERSON
          I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
                               A. Derrill Crowe
          ---------------------------------------------------------------------

  (2)     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*         (a)   [   ]
                                                                    (b)   [   ]

          ---------------------------------------------------------------------

  (3)     SEC USE ONLY

          ---------------------------------------------------------------------

  (4)     CITIZENSHIP OR PLACE OR ORGANIZATION
                               United States
          ---------------------------------------------------------------------

                       (5)     SOLE VOTING POWER
  NUMBER OF                    2,404,452
   SHARES              --------------------------------------------------------
 BENEFICIALLY          (6)     SHARED VOTING POWER
  OWNED BY
    EACH               --------------------------------------------------------
  REPORTING            (7)     SOLE DISPOSITIVE POWER
 PERSON WITH                   2,404,452
                       --------------------------------------------------------
                       (8)     SHARED DISPOSITIVE POWER

                       --------------------------------------------------------

 (9)     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                               2,404,452
          ---------------------------------------------------------------------

 (10)     CHECK BOX IF AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
          SHARES*
                               See Item 4
          ---------------------------------------------------------------------

 (11)     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
                               9.7%
          ---------------------------------------------------------------------

 (12)     TYPE OF REPORTING PERSON*
                               IN
          ---------------------------------------------------------------------
                    *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>   3

                                AMENDMENT NO. 2
                                 SCHEDULE 13G
                                FILED WITH THE
                      SECURITIES AND EXCHANGE COMMISSION
                                 ON BEHALF OF
                            A. DERRILL CROWE, M.D.

Item 1(a) Name of Issuer:

     Medical Assurance, Inc. (Formerly MAIC Holdings, Inc.)

The reporting person originally filed a Schedule 13G with respect to Mutual
Assurance, Inc. (Cusip No. 62823T 10 1) on February 14, 1992, as amended
February 15, 1994. On August 31, 1995, MAIC Holdings, Inc. became the successor
registrant to Mutual Assurance, Inc. Pursuant to Rule 12g-3 of the SEC. On
September 23, 1996, MAIC Holdings, Inc. registered its common stock under
Section 12(b) of the Securities Exchange Act of 1934 upon listing its common
stock on the New York Stock Exchange (CUSIP No. 55261 V 10 9). Effective
June 1, 1997, MAIC Holdings changed its name to Medical Assurance, Inc.
(CUSIP No. 59449 U 10 0).

Item 1(b) Address of Issuer's Principal Executive Offices:

     100 Brookwood Place
     Birmingham, AL 35209

Item 2(a) Name of Person Filing:

     A. Derrill Crowe, M.D.

Item 2(b) Address of Principal Business Office:

     Medical Assurance, Inc.
     100 Brookwood Place
     Birmingham, AL 35209

Item 2(c) Citizenship

     United States of America

Item 2(d) Title of Class of Securities:

     Common Stock, $1.00 par value per share



                                       3
<PAGE>   4
Item 2(e) CUSP NUMBER
          -----------

       58449U 10 0

Item 3

       Not Applicable

Item 4     Ownership:
           ----------

       (a) Amount Beneficially Owned:*

           2,404,452 shares

       (b) Percent of Class:*

           9.7%

       (c) Number of Shares as to which such Person has:*

           (i) Sole power to vote or to direct the vote:

               2,404,452 shares

          (ii) Shared power to vote or to direct the vote:

               None

         (iii) Sole power to dispose or to direct the disposition of:

               2,404,452 shares

          (iv) Shared power to dispose or to direct the disposition of

               None

*Includes shares distributed as a result of stock dividends declared in 1993,
1994, 1995, 1996, 1997 and 1998, and the two-for-one-stock split in 1997. Also
includes stock dividend declared in 1999 for distribution in February, 2000.
Does not include 11,183 shares held for the account of Dr. Crowe in the Medical
Assurance, Inc. Pension Plan and 1,224 shares owned of record by his spouse.


                                       4


<PAGE>   5
Item 5     Ownership of Five Percent or Less of a Class

        Not applicable

Item 6     Ownership of More Than Five Percent on Behalf of Another Person

        Not applicable

Item 7     Identification and Classification of the Subsidiary Which Acquired
           the Securities Being Reported On By the Parent Holding Company

        Not applicable

Item 8     Identification and Classification of Members of the Group

        Not applicable

Item 9     Notice of Dissolution Group

        Not applicable

Item 10     Certification

        Not applicable


                                   SIGNATURES

           After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete
and correct.

                                                       February 11, 2000


                                                       /s/ A. Derrill Crowe
                                                       -----------------------
                                                       A. Derrill Crowe

                                       5


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission